Ram Nagaraj
Concepts (470)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lens, Crystalline | 53 | 2026 | 136 | 14.230 |
Why?
| | Glycation End Products, Advanced | 40 | 2026 | 82 | 9.320 |
Why?
| | Crystallins | 32 | 2025 | 61 | 7.250 |
Why?
| | Lysine | 32 | 2026 | 302 | 5.170 |
Why?
| | Pyruvaldehyde | 30 | 2025 | 50 | 5.000 |
Why?
| | Cataract | 26 | 2026 | 238 | 4.800 |
Why?
| | Epithelial Cells | 18 | 2025 | 1126 | 4.190 |
Why?
| | Molecular Chaperones | 18 | 2022 | 200 | 3.890 |
Why?
| | alpha-Crystallin B Chain | 12 | 2020 | 24 | 3.820 |
Why?
| | Epithelial-Mesenchymal Transition | 8 | 2025 | 220 | 3.520 |
Why?
| | Transforming Growth Factor beta2 | 7 | 2025 | 33 | 3.370 |
Why?
| | alpha-Crystallin A Chain | 8 | 2020 | 13 | 2.890 |
Why?
| | Arginine | 24 | 2026 | 262 | 2.860 |
Why?
| | Kynurenine | 11 | 2016 | 114 | 2.830 |
Why?
| | Apoptosis | 16 | 2025 | 2430 | 2.520 |
Why?
| | Maillard Reaction | 29 | 2015 | 30 | 2.310 |
Why?
| | Presbyopia | 4 | 2023 | 15 | 2.300 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2025 | 31 | 2.080 |
Why?
| | Lens Capsule, Crystalline | 3 | 2024 | 13 | 1.990 |
Why?
| | Capsule Opacification | 4 | 2020 | 22 | 1.820 |
Why?
| | Diabetic Retinopathy | 8 | 2025 | 208 | 1.820 |
Why?
| | Retinal Vessels | 8 | 2025 | 77 | 1.780 |
Why?
| | Eye Proteins | 6 | 2018 | 91 | 1.720 |
Why?
| | alpha-Crystallins | 7 | 2019 | 13 | 1.690 |
Why?
| | Glaucoma | 3 | 2022 | 250 | 1.680 |
Why?
| | Aging | 22 | 2020 | 1966 | 1.620 |
Why?
| | Ocular Hypertension | 3 | 2025 | 70 | 1.600 |
Why?
| | Diabetes Mellitus, Experimental | 14 | 2020 | 198 | 1.580 |
Why?
| | HSP27 Heat-Shock Proteins | 4 | 2015 | 13 | 1.530 |
Why?
| | Protein Processing, Post-Translational | 6 | 2026 | 477 | 1.470 |
Why?
| | Ornithine | 11 | 2017 | 28 | 1.420 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 8 | 2018 | 55 | 1.370 |
Why?
| | Cysteine | 3 | 2025 | 210 | 1.350 |
Why?
| | Peptides | 5 | 2021 | 998 | 1.270 |
Why?
| | Reperfusion Injury | 2 | 2025 | 300 | 1.250 |
Why?
| | Glyoxal | 3 | 2025 | 15 | 1.250 |
Why?
| | gamma-Crystallins | 3 | 2026 | 5 | 1.230 |
Why?
| | Ascorbic Acid | 9 | 2017 | 180 | 1.220 |
Why?
| | Protein Deglycase DJ-1 | 2 | 2025 | 15 | 1.160 |
Why?
| | Sirtuins | 2 | 2019 | 50 | 1.160 |
Why?
| | Sirtuin 3 | 2 | 2019 | 60 | 1.130 |
Why?
| | Animals | 69 | 2025 | 38109 | 1.060 |
Why?
| | Tandem Mass Spectrometry | 8 | 2026 | 577 | 1.030 |
Why?
| | Endothelial Cells | 6 | 2025 | 870 | 1.030 |
Why?
| | Glutathione | 10 | 2020 | 375 | 1.020 |
Why?
| | Lactoylglutathione Lyase | 7 | 2010 | 19 | 1.010 |
Why?
| | Cattle | 24 | 2020 | 1000 | 1.000 |
Why?
| | Acetylation | 9 | 2024 | 256 | 1.000 |
Why?
| | Cellular Senescence | 3 | 2024 | 226 | 0.990 |
Why?
| | Cells, Cultured | 19 | 2025 | 4155 | 0.970 |
Why?
| | Retinal Ganglion Cells | 4 | 2025 | 121 | 0.970 |
Why?
| | Blotting, Western | 14 | 2025 | 1187 | 0.960 |
Why?
| | Chromatography, Liquid | 8 | 2024 | 454 | 0.940 |
Why?
| | Imidazoles | 7 | 2012 | 254 | 0.900 |
Why?
| | Choroidal Neovascularization | 1 | 2025 | 57 | 0.850 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4569 | 0.850 |
Why?
| | Pyrimidines | 11 | 2017 | 533 | 0.850 |
Why?
| | Endothelium, Vascular | 4 | 2025 | 965 | 0.840 |
Why?
| | Antibodies, Monoclonal | 6 | 2019 | 1524 | 0.840 |
Why?
| | Mice | 23 | 2025 | 18365 | 0.830 |
Why?
| | Heat-Shock Proteins | 5 | 2022 | 138 | 0.800 |
Why?
| | Sulfhydryl Compounds | 2 | 2024 | 189 | 0.790 |
Why?
| | Pericytes | 5 | 2012 | 36 | 0.790 |
Why?
| | Ultraviolet Rays | 3 | 2017 | 388 | 0.780 |
Why?
| | Tetroses | 3 | 2020 | 5 | 0.770 |
Why?
| | Glucose | 14 | 2017 | 1049 | 0.750 |
Why?
| | Humans | 92 | 2026 | 144957 | 0.730 |
Why?
| | Eye Diseases | 2 | 2015 | 94 | 0.710 |
Why?
| | Glycosylation | 12 | 2020 | 172 | 0.710 |
Why?
| | Capillaries | 5 | 2025 | 124 | 0.700 |
Why?
| | Proteins | 9 | 2021 | 1022 | 0.700 |
Why?
| | Chromatography, High Pressure Liquid | 18 | 2010 | 598 | 0.680 |
Why?
| | Mice, Inbred C57BL | 10 | 2025 | 5997 | 0.640 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.630 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.630 |
Why?
| | Posterior Capsule of the Lens | 1 | 2020 | 11 | 0.620 |
Why?
| | Malonates | 1 | 2019 | 9 | 0.620 |
Why?
| | Propionates | 1 | 2019 | 39 | 0.610 |
Why?
| | Tryptophan | 7 | 2013 | 181 | 0.580 |
Why?
| | Fibrosis | 2 | 2025 | 548 | 0.580 |
Why?
| | Fibronectins | 4 | 2024 | 136 | 0.560 |
Why?
| | Diabetes Mellitus | 14 | 2024 | 1098 | 0.540 |
Why?
| | Spectrometry, Fluorescence | 9 | 2012 | 168 | 0.520 |
Why?
| | Aged | 31 | 2024 | 25947 | 0.510 |
Why?
| | Lipid Bilayers | 2 | 2010 | 103 | 0.510 |
Why?
| | Immunohistochemistry | 7 | 2019 | 1718 | 0.500 |
Why?
| | Cell Line | 7 | 2020 | 2882 | 0.500 |
Why?
| | Mice, Knockout | 6 | 2025 | 3125 | 0.500 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 338 | 0.500 |
Why?
| | MAP Kinase Signaling System | 2 | 2018 | 311 | 0.490 |
Why?
| | Aspirin | 1 | 2020 | 400 | 0.490 |
Why?
| | Circular Dichroism | 6 | 2019 | 150 | 0.490 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 298 | 0.470 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 12 | 2018 | 851 | 0.460 |
Why?
| | Cross-Linking Reagents | 10 | 2020 | 207 | 0.450 |
Why?
| | HSP20 Heat-Shock Proteins | 1 | 2015 | 2 | 0.440 |
Why?
| | Proteomics | 2 | 2024 | 1195 | 0.440 |
Why?
| | Protein Structure, Tertiary | 7 | 2013 | 862 | 0.440 |
Why?
| | Protein Aggregation, Pathological | 1 | 2015 | 22 | 0.440 |
Why?
| | Pyridoxamine | 2 | 2006 | 2 | 0.440 |
Why?
| | Rats | 16 | 2025 | 5614 | 0.420 |
Why?
| | Protein Structure, Secondary | 6 | 2013 | 369 | 0.420 |
Why?
| | Histones | 1 | 2020 | 670 | 0.420 |
Why?
| | Blood Proteins | 8 | 2009 | 249 | 0.410 |
Why?
| | Brain Diseases | 1 | 2015 | 153 | 0.400 |
Why?
| | Amino Acid Sequence | 8 | 2015 | 2157 | 0.400 |
Why?
| | Retina | 5 | 2025 | 324 | 0.390 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 47 | 0.380 |
Why?
| | Solubility | 4 | 2023 | 242 | 0.380 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2013 | 192 | 0.380 |
Why?
| | Disulfides | 2 | 2023 | 96 | 0.370 |
Why?
| | Pyrroles | 7 | 2009 | 218 | 0.370 |
Why?
| | Mass Spectrometry | 6 | 2019 | 750 | 0.370 |
Why?
| | Intraocular Pressure | 3 | 2025 | 328 | 0.360 |
Why?
| | Paraffin Embedding | 2 | 2024 | 33 | 0.360 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2018 | 331 | 0.360 |
Why?
| | Protein Conformation | 7 | 2019 | 946 | 0.360 |
Why?
| | Interferon-gamma | 3 | 2018 | 784 | 0.350 |
Why?
| | Organ Culture Techniques | 5 | 2019 | 154 | 0.340 |
Why?
| | Water | 3 | 2023 | 469 | 0.340 |
Why?
| | Caspase 3 | 5 | 2013 | 238 | 0.340 |
Why?
| | HeLa Cells | 4 | 2016 | 650 | 0.340 |
Why?
| | Citrate (si)-Synthase | 4 | 2020 | 57 | 0.340 |
Why?
| | Protein Binding | 6 | 2020 | 2276 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2010 | 11 | 0.320 |
Why?
| | Aquaporins | 1 | 2010 | 8 | 0.320 |
Why?
| | Middle Aged | 24 | 2024 | 35928 | 0.320 |
Why?
| | Caspase 9 | 4 | 2013 | 55 | 0.320 |
Why?
| | Myristic Acid | 2 | 2010 | 10 | 0.310 |
Why?
| | Protein Denaturation | 4 | 2020 | 75 | 0.310 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2010 | 93 | 0.310 |
Why?
| | Membrane Lipids | 1 | 2010 | 83 | 0.310 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2609 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2010 | 187 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 9 | 2015 | 2540 | 0.300 |
Why?
| | Actins | 3 | 2020 | 425 | 0.290 |
Why?
| | Protein Folding | 1 | 2010 | 279 | 0.280 |
Why?
| | Norleucine | 4 | 1996 | 4 | 0.280 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2931 | 0.270 |
Why?
| | Aldehyde Reductase | 4 | 2006 | 31 | 0.270 |
Why?
| | Structure-Activity Relationship | 4 | 2015 | 570 | 0.270 |
Why?
| | Amides | 2 | 2026 | 101 | 0.260 |
Why?
| | Cloning, Molecular | 4 | 2010 | 541 | 0.260 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 269 | 0.260 |
Why?
| | Signal Transduction | 5 | 2025 | 5233 | 0.260 |
Why?
| | Reactive Oxygen Species | 7 | 2018 | 621 | 0.250 |
Why?
| | Lens Diseases | 1 | 2006 | 3 | 0.250 |
Why?
| | Cricetulus | 3 | 2013 | 118 | 0.250 |
Why?
| | CHO Cells | 3 | 2013 | 171 | 0.250 |
Why?
| | Cricetinae | 3 | 2013 | 304 | 0.250 |
Why?
| | Adult | 23 | 2020 | 40506 | 0.250 |
Why?
| | Asparagine | 1 | 2026 | 35 | 0.240 |
Why?
| | Hyperglycemia | 3 | 2012 | 375 | 0.240 |
Why?
| | Aspartic Acid | 1 | 2026 | 88 | 0.230 |
Why?
| | Dipeptides | 1 | 2005 | 57 | 0.230 |
Why?
| | Enzyme Activation | 4 | 2010 | 768 | 0.230 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 2032 | 0.230 |
Why?
| | Cytokines | 1 | 2013 | 2065 | 0.230 |
Why?
| | Molecular Structure | 6 | 2012 | 501 | 0.230 |
Why?
| | Quinoxalines | 1 | 2005 | 65 | 0.230 |
Why?
| | Galactosemias | 3 | 2000 | 16 | 0.220 |
Why?
| | Alkylation | 1 | 2025 | 27 | 0.220 |
Why?
| | GAP-43 Protein | 1 | 2025 | 7 | 0.220 |
Why?
| | Cell Cycle | 1 | 2008 | 597 | 0.220 |
Why?
| | Synapsins | 1 | 2025 | 13 | 0.220 |
Why?
| | Histidine | 1 | 2005 | 66 | 0.220 |
Why?
| | Serum Albumin | 2 | 2008 | 147 | 0.220 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 20 | 0.220 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1253 | 0.220 |
Why?
| | Down-Regulation | 3 | 2013 | 627 | 0.220 |
Why?
| | Diabetes Complications | 1 | 2006 | 223 | 0.220 |
Why?
| | Retinal Pigment Epithelium | 1 | 2025 | 80 | 0.220 |
Why?
| | Protein Transport | 3 | 2015 | 441 | 0.220 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2007 | 631 | 0.210 |
Why?
| | Laser Coagulation | 1 | 2025 | 77 | 0.210 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 8 | 0.210 |
Why?
| | Benzamides | 1 | 2025 | 224 | 0.210 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2025 | 145 | 0.210 |
Why?
| | Protein Kinase C | 1 | 2005 | 252 | 0.210 |
Why?
| | Formaldehyde | 1 | 2024 | 66 | 0.210 |
Why?
| | Protein Aggregates | 2 | 2015 | 86 | 0.210 |
Why?
| | Mutation | 3 | 2015 | 4099 | 0.210 |
Why?
| | Glomerular Mesangium | 1 | 2003 | 21 | 0.200 |
Why?
| | Male | 16 | 2025 | 72406 | 0.200 |
Why?
| | Neuroprotective Agents | 1 | 2025 | 143 | 0.200 |
Why?
| | Calmodulin | 1 | 2003 | 70 | 0.200 |
Why?
| | Axonal Transport | 2 | 2022 | 26 | 0.200 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2003 | 86 | 0.190 |
Why?
| | Proline | 1 | 2003 | 83 | 0.190 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 271 | 0.190 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2002 | 5 | 0.190 |
Why?
| | NF-kappa B | 2 | 2025 | 662 | 0.190 |
Why?
| | Imidazolidines | 2 | 1994 | 10 | 0.190 |
Why?
| | Neuroprotection | 1 | 2022 | 46 | 0.180 |
Why?
| | Ribose | 3 | 2017 | 22 | 0.180 |
Why?
| | Temperature | 2 | 2020 | 679 | 0.180 |
Why?
| | Amino Acids | 4 | 2017 | 522 | 0.180 |
Why?
| | Oxidation-Reduction | 2 | 2017 | 1087 | 0.180 |
Why?
| | Cytochromes c | 2 | 2013 | 53 | 0.170 |
Why?
| | Capsulorhexis | 1 | 2021 | 9 | 0.170 |
Why?
| | Age Factors | 4 | 2019 | 3335 | 0.170 |
Why?
| | Recombinant Proteins | 3 | 2012 | 1371 | 0.170 |
Why?
| | Acetone | 1 | 2001 | 12 | 0.170 |
Why?
| | Oxidative Stress | 2 | 2005 | 1339 | 0.170 |
Why?
| | Malate Dehydrogenase | 1 | 2020 | 1 | 0.170 |
Why?
| | Epitopes | 2 | 2005 | 485 | 0.170 |
Why?
| | Fluorescence | 5 | 2015 | 161 | 0.170 |
Why?
| | Beer | 1 | 2001 | 13 | 0.170 |
Why?
| | Models, Molecular | 4 | 2017 | 1619 | 0.170 |
Why?
| | Anti-Infective Agents | 1 | 2003 | 242 | 0.160 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2015 | 381 | 0.160 |
Why?
| | Phosphorylation | 6 | 2010 | 1733 | 0.160 |
Why?
| | Diabetic Angiopathies | 1 | 2002 | 263 | 0.160 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 318 | 0.160 |
Why?
| | Lipids | 1 | 2005 | 710 | 0.160 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2002 | 452 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2020 | 86 | 0.150 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 108 | 0.150 |
Why?
| | Mice, Transgenic | 3 | 2010 | 2185 | 0.150 |
Why?
| | Oxalates | 1 | 1999 | 11 | 0.150 |
Why?
| | Thermodynamics | 2 | 2012 | 426 | 0.150 |
Why?
| | Antibody Specificity | 3 | 2009 | 181 | 0.150 |
Why?
| | Multiprotein Complexes | 1 | 2020 | 172 | 0.150 |
Why?
| | Succinates | 1 | 2019 | 24 | 0.150 |
Why?
| | Spectrophotometry | 4 | 2005 | 61 | 0.150 |
Why?
| | Blood Glucose | 3 | 2021 | 2330 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 156 | 0.150 |
Why?
| | Adolescent | 10 | 2020 | 22453 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2019 | 1167 | 0.140 |
Why?
| | Gain of Function Mutation | 1 | 2019 | 36 | 0.140 |
Why?
| | Cytosol | 1 | 2019 | 227 | 0.140 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 919 | 0.140 |
Why?
| | Aged, 80 and over | 10 | 2015 | 8279 | 0.140 |
Why?
| | Young Adult | 4 | 2020 | 14126 | 0.140 |
Why?
| | Retinal Degeneration | 1 | 2018 | 40 | 0.130 |
Why?
| | Binding Sites | 2 | 2012 | 1331 | 0.130 |
Why?
| | CD55 Antigens | 1 | 2017 | 29 | 0.130 |
Why?
| | Kinetics | 3 | 2012 | 1629 | 0.130 |
Why?
| | Calcium | 1 | 2003 | 1184 | 0.130 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 263 | 0.130 |
Why?
| | Antioxidants | 2 | 2015 | 549 | 0.130 |
Why?
| | Collagen | 3 | 1996 | 456 | 0.130 |
Why?
| | Deoxyglucose | 2 | 1996 | 51 | 0.120 |
Why?
| | Dura Mater | 2 | 1996 | 35 | 0.120 |
Why?
| | Snail Family Transcription Factors | 1 | 2016 | 18 | 0.120 |
Why?
| | Smad3 Protein | 1 | 2016 | 43 | 0.120 |
Why?
| | Monosaccharides | 3 | 2003 | 13 | 0.120 |
Why?
| | Smad2 Protein | 1 | 2016 | 37 | 0.120 |
Why?
| | Basement Membrane | 1 | 2016 | 32 | 0.120 |
Why?
| | Smad4 Protein | 1 | 2016 | 34 | 0.120 |
Why?
| | Caproates | 1 | 1995 | 5 | 0.120 |
Why?
| | Models, Chemical | 3 | 2005 | 269 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2013 | 897 | 0.110 |
Why?
| | Microscopy, Fluorescence | 2 | 2008 | 418 | 0.110 |
Why?
| | Selenious Acid | 1 | 2015 | 3 | 0.110 |
Why?
| | RNA, Messenger | 3 | 2016 | 2832 | 0.110 |
Why?
| | Binding, Competitive | 3 | 2008 | 193 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2010 | 437 | 0.110 |
Why?
| | Photobleaching | 1 | 2015 | 24 | 0.110 |
Why?
| | Injections, Intraperitoneal | 1 | 2015 | 117 | 0.110 |
Why?
| | Flow Cytometry | 3 | 2010 | 1173 | 0.110 |
Why?
| | Dimerization | 2 | 2007 | 194 | 0.110 |
Why?
| | Caspases | 2 | 2006 | 232 | 0.110 |
Why?
| | Stereoisomerism | 2 | 2005 | 105 | 0.100 |
Why?
| | Models, Biological | 3 | 2010 | 1822 | 0.100 |
Why?
| | Glycoproteins | 1 | 1996 | 355 | 0.100 |
Why?
| | Heat-Shock Response | 1 | 2015 | 78 | 0.100 |
Why?
| | Peroxynitrous Acid | 1 | 2013 | 12 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 2 | 2010 | 623 | 0.100 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 49 | 0.100 |
Why?
| | Glycine | 1 | 2014 | 187 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 965 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2013 | 162 | 0.100 |
Why?
| | Time Factors | 5 | 2006 | 7183 | 0.100 |
Why?
| | Algorithms | 1 | 2021 | 1839 | 0.100 |
Why?
| | Insulin | 4 | 2010 | 2507 | 0.090 |
Why?
| | RNA | 1 | 2019 | 940 | 0.090 |
Why?
| | Enzyme Inhibitors | 2 | 2010 | 826 | 0.090 |
Why?
| | Acetic Anhydrides | 1 | 2011 | 3 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 224 | 0.090 |
Why?
| | Transfection | 2 | 2004 | 940 | 0.090 |
Why?
| | Extracellular Matrix | 1 | 2016 | 553 | 0.090 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2005 | 12 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 476 | 0.090 |
Why?
| | Biomarkers | 3 | 2016 | 4275 | 0.090 |
Why?
| | Microscopy, Confocal | 2 | 2004 | 321 | 0.090 |
Why?
| | Chromatography, Gel | 2 | 2005 | 131 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 983 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 395 | 0.090 |
Why?
| | Cell Membrane | 2 | 2005 | 706 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2011 | 106 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 619 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2015 | 453 | 0.090 |
Why?
| | Glutamine | 1 | 2011 | 109 | 0.080 |
Why?
| | Dogs | 3 | 2005 | 438 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 396 | 0.080 |
Why?
| | Base Sequence | 2 | 2015 | 2191 | 0.080 |
Why?
| | Guanidines | 3 | 2000 | 41 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 509 | 0.080 |
Why?
| | Drug Antagonism | 1 | 2010 | 9 | 0.080 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 22 | 0.080 |
Why?
| | Female | 12 | 2024 | 78376 | 0.080 |
Why?
| | Tetrazoles | 1 | 2010 | 50 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1054 | 0.080 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 85 | 0.080 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 37 | 0.080 |
Why?
| | Buffers | 1 | 2009 | 55 | 0.080 |
Why?
| | Resins, Synthetic | 1 | 2009 | 14 | 0.080 |
Why?
| | Edetic Acid | 1 | 2009 | 47 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2010 | 25 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 1 | 2010 | 54 | 0.080 |
Why?
| | Caspase Inhibitors | 1 | 2010 | 81 | 0.080 |
Why?
| | Benzimidazoles | 1 | 2010 | 190 | 0.070 |
Why?
| | DNA Primers | 1 | 2010 | 512 | 0.070 |
Why?
| | Complement System Proteins | 1 | 2012 | 316 | 0.070 |
Why?
| | Surface Properties | 1 | 2010 | 410 | 0.070 |
Why?
| | Alzheimer Disease | 3 | 2010 | 622 | 0.070 |
Why?
| | In Vitro Techniques | 2 | 2009 | 1048 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.070 |
Why?
| | Umbilical Veins | 2 | 2008 | 59 | 0.070 |
Why?
| | Myosin Type II | 1 | 2008 | 18 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 165 | 0.070 |
Why?
| | Homoarginine | 1 | 2008 | 2 | 0.070 |
Why?
| | Methylurea Compounds | 1 | 2008 | 7 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 336 | 0.070 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2024 | 138 | 0.070 |
Why?
| | Antibodies | 2 | 2000 | 403 | 0.070 |
Why?
| | Oxygen | 2 | 2005 | 995 | 0.070 |
Why?
| | Doxorubicin | 1 | 2010 | 397 | 0.060 |
Why?
| | Serum Albumin, Bovine | 3 | 2000 | 62 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2008 | 206 | 0.060 |
Why?
| | Autoantibodies | 2 | 2012 | 1504 | 0.060 |
Why?
| | Protein Subunits | 1 | 2008 | 226 | 0.060 |
Why?
| | Uremia | 3 | 2008 | 15 | 0.060 |
Why?
| | Rabbits | 2 | 1998 | 648 | 0.060 |
Why?
| | Frameshift Mutation | 1 | 2007 | 32 | 0.060 |
Why?
| | Fatty Acids | 1 | 2010 | 452 | 0.060 |
Why?
| | Macular Degeneration | 1 | 2009 | 191 | 0.060 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 2 | 1996 | 7 | 0.060 |
Why?
| | Carbonic Anhydrases | 1 | 2006 | 12 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2010 | 511 | 0.060 |
Why?
| | Nitroso Compounds | 1 | 2006 | 7 | 0.060 |
Why?
| | Nitric Oxide Donors | 1 | 2006 | 20 | 0.060 |
Why?
| | Hemocyanins | 1 | 2005 | 61 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 304 | 0.060 |
Why?
| | Iodides | 1 | 2005 | 11 | 0.060 |
Why?
| | Myristic Acids | 1 | 2005 | 8 | 0.060 |
Why?
| | Sweetening Agents | 1 | 2006 | 57 | 0.060 |
Why?
| | Ninhydrin | 1 | 2005 | 1 | 0.060 |
Why?
| | Rats, Inbred BN | 1 | 2025 | 55 | 0.060 |
Why?
| | Diffusion | 1 | 2005 | 122 | 0.060 |
Why?
| | Fructose | 1 | 2005 | 130 | 0.060 |
Why?
| | Cytoplasm | 1 | 2005 | 269 | 0.050 |
Why?
| | Reference Values | 3 | 1997 | 798 | 0.050 |
Why?
| | Tissue Fixation | 1 | 2024 | 37 | 0.050 |
Why?
| | Magnesium Oxide | 1 | 2024 | 1 | 0.050 |
Why?
| | Acetylcysteine | 1 | 2005 | 139 | 0.050 |
Why?
| | Ependymoglial Cells | 1 | 2024 | 8 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2010 | 2050 | 0.050 |
Why?
| | CD40 Ligand | 1 | 2024 | 40 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2005 | 178 | 0.050 |
Why?
| | Laminin | 1 | 2024 | 72 | 0.050 |
Why?
| | Erythrocytes | 2 | 2017 | 757 | 0.050 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2003 | 10 | 0.050 |
Why?
| | Alcohol Dehydrogenase | 1 | 2003 | 16 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2003 | 43 | 0.050 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2003 | 73 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2024 | 90 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 347 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3415 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 266 | 0.050 |
Why?
| | Galectin 3 | 1 | 2003 | 21 | 0.050 |
Why?
| | Mitochondria | 1 | 2010 | 984 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 852 | 0.050 |
Why?
| | Semicarbazides | 1 | 2002 | 1 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 292 | 0.050 |
Why?
| | Kidney Glomerulus | 1 | 2003 | 128 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 29 | 0.050 |
Why?
| | Retinal Neovascularization | 1 | 2002 | 29 | 0.050 |
Why?
| | Oligopeptides | 1 | 2004 | 269 | 0.050 |
Why?
| | Child | 4 | 2015 | 22657 | 0.040 |
Why?
| | Deoxyribose | 1 | 2001 | 6 | 0.040 |
Why?
| | Carbohydrate Metabolism | 1 | 2001 | 61 | 0.040 |
Why?
| | Serum Albumin, Human | 1 | 2000 | 7 | 0.040 |
Why?
| | Molecular Weight | 2 | 1991 | 327 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2499 | 0.040 |
Why?
| | Color | 1 | 2001 | 81 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2001 | 131 | 0.040 |
Why?
| | Carbohydrates | 1 | 2000 | 66 | 0.040 |
Why?
| | Muramidase | 1 | 2000 | 67 | 0.040 |
Why?
| | Chelating Agents | 1 | 2000 | 73 | 0.040 |
Why?
| | Aldehydes | 1 | 2001 | 142 | 0.040 |
Why?
| | Aorta | 1 | 2002 | 430 | 0.040 |
Why?
| | Alkanes | 1 | 1999 | 14 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1999 | 143 | 0.040 |
Why?
| | Galactose | 2 | 2000 | 34 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 1998 | 44 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1311 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 906 | 0.030 |
Why?
| | Glyceraldehyde | 1 | 1997 | 2 | 0.030 |
Why?
| | Inclusion Bodies | 1 | 1997 | 27 | 0.030 |
Why?
| | Neurosciences | 1 | 1997 | 25 | 0.030 |
Why?
| | Photosensitizing Agents | 1 | 1997 | 42 | 0.030 |
Why?
| | Amyloid | 1 | 1997 | 92 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2017 | 234 | 0.030 |
Why?
| | Glycosuria | 1 | 1996 | 10 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1496 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2012 | 893 | 0.030 |
Why?
| | Aminocaproates | 1 | 1995 | 3 | 0.030 |
Why?
| | Ethers | 1 | 1996 | 19 | 0.030 |
Why?
| | Neurofilament Proteins | 1 | 1996 | 80 | 0.030 |
Why?
| | Scattering, Radiation | 1 | 2015 | 103 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2014 | 33 | 0.030 |
Why?
| | Galactitol | 1 | 1994 | 1 | 0.030 |
Why?
| | Complement Activation | 1 | 2017 | 411 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1126 | 0.020 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 56 | 0.020 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2012 | 43 | 0.020 |
Why?
| | Pronase | 1 | 1992 | 5 | 0.020 |
Why?
| | Serum | 1 | 2012 | 59 | 0.020 |
Why?
| | Child, Preschool | 1 | 2007 | 11799 | 0.020 |
Why?
| | Diabetic Neuropathies | 1 | 1993 | 100 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3608 | 0.020 |
Why?
| | Pigmentation | 1 | 1991 | 53 | 0.020 |
Why?
| | Hydrolysis | 1 | 1991 | 199 | 0.020 |
Why?
| | Renin | 1 | 2010 | 34 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 321 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2010 | 68 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2012 | 379 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2010 | 250 | 0.020 |
Why?
| | Fluorometry | 1 | 2009 | 18 | 0.020 |
Why?
| | Autoantigens | 1 | 2012 | 429 | 0.020 |
Why?
| | NADPH Oxidase 4 | 1 | 2008 | 8 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 40 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 35 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2008 | 124 | 0.020 |
Why?
| | Diet | 1 | 1994 | 1275 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 496 | 0.010 |
Why?
| | Amines | 2 | 1997 | 40 | 0.010 |
Why?
| | Hippocampus | 1 | 2010 | 967 | 0.010 |
Why?
| | Logistic Models | 1 | 2009 | 2119 | 0.010 |
Why?
| | Endothelium, Corneal | 1 | 2003 | 19 | 0.010 |
Why?
| | Epiretinal Membrane | 1 | 2002 | 7 | 0.010 |
Why?
| | Retinal Vasculitis | 1 | 2002 | 12 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2003 | 334 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 200 | 0.010 |
Why?
| | Photochemistry | 1 | 2002 | 134 | 0.010 |
Why?
| | Cell Communication | 1 | 2003 | 324 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2000 | 121 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1642 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1098 | 0.010 |
Why?
| | Alkalies | 1 | 1996 | 5 | 0.010 |
Why?
| | Guanidine | 1 | 1996 | 20 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 1996 | 26 | 0.010 |
Why?
| | Cell Fractionation | 1 | 1996 | 52 | 0.010 |
Why?
| | Formates | 1 | 1996 | 16 | 0.010 |
Why?
| | Densitometry | 1 | 1996 | 38 | 0.010 |
Why?
| | Endopeptidases | 1 | 1996 | 82 | 0.010 |
Why?
| | Urea | 1 | 1996 | 84 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 300 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 415 | 0.010 |
Why?
| | Hemostatics | 1 | 1996 | 61 | 0.010 |
Why?
| | Peritoneal Dialysis | 1 | 1996 | 100 | 0.010 |
Why?
| | Renal Dialysis | 1 | 1996 | 462 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 1992 | 159 | 0.010 |
Why?
| | Axons | 1 | 1993 | 201 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 1996 | 598 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1989 | 561 | 0.000 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 1993 | 2584 | 0.000 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3890 | 0.000 |
Why?
|
|
Nagaraj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|